CHARLESTOWN, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced a grant of 11,950 restricted stock units (“RSUs”) to one newly hired employee.
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Seeking Alpha / 24 minutes from now 1 Views
Comments